Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
e-SPACE Cardio-Renal-Metabolic 2025 – Day Two
Author(s): Nisha Bansal, Antonio Ceriello, David Wheeler ,et al Start date: Apr 05, 2025

Heart Failure

Prevention & Chronic Conditions
e-SPACE Cardio-Renal-Metabolic 2025 – Day One
Author(s): Nisha Bansal, Antonio Ceriello, David Wheeler ,et al Start date: Apr 04, 2025

Heart Failure

Prevention & Chronic Conditions
Kai Pardey
Job title: Commercial Director
Kai Pardey is Commercial Director at the Lübeck campus of University Hospital Schleswig-Holstein. He oversees strategic, financial, and operational management within a large academic healthcare organisation. His work focuses on sustainable hospital operations, innovation, and cross-disciplinary collaboration between clinical, academic, and industry partners. View more
Breakthrough Mineralocorticoid Receptor Agonists in Cardiovascular Care
Author(s): Javed Butler , Dinesh Khullar , John JV McMurray , et al Added: 7 months ago
In this expert-led webinar moderated by Dr Vijay Chopra, leading clinicians review current and emerging strategies in aldosterone modulation, hyperkalaemia management, and cardiorenal therapeutics.Dr Javed Butler opens with a practical overview of aldosterone’s central role in heart failure and CKD, emphasising the importance of achieving guideline-directed RAAS inhibitor and MRA dosing. He… View more

Prevention & Chronic Conditions

Heart Failure
Start date: Feb 25, 2025 End date: Feb 26, 2025
Due to the recent success of New Horizons in Amyloidosis, Radcliffe Cardiology are excited to introduce a new 2-day event ‘New Horizons in Cardiomyopathy’ (NHC) in February 2025.The event, hosted on Radcliffe Cardiology, will be streamed on Tuesday 25 February - Wednesday 26February 2025. It promises an interactive and informative experience, updating professionals on cardiac amyloidosis and… View more

Heart Failure
AHA 25: HFpEF as an Adipose Tissue Disorder
Author(s): Milton Packer Added: 7 months ago
AHA Scientific Sessions 2025 - Dr Milton Packer (Baylor University Medical Center, US) joins us to discuss his novel unifying hypothesis that heart failure with preserved ejection fraction arises primarily from visceral adipose tissue dysfunction and altered adipokine signaling, rather than as a heterogeneous disorder driven by multiple comorbidities.Interview Questions:Can you explain the core… View more

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
Job title: Digital Content Manager
Plaque Burden on CCTA Predicts MACE in Early CAD
Added: 3 months ago Source:  Radcliffe Vascular
A post hoc analysis of the PROMISE trial has found that quantitative coronary plaque measures derived from coronary computed tomographic angiography (CCTA) can independently predict major adverse cardiovascular events (MACE) in symptomatic patients without a known history of coronary artery disease (CAD).¹ The findings suggest that total plaque burden and noncalcified plaque burden may enhance… View more

Imaging & Diagnostics

Prevention & Chronic Conditions